Variant report

Variant	esv3440728
Chromosome Location	chr21:44595883-44600181
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:47)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:47 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:45609823..45610333-chr21:44597019..44597949,2	Hela-S3	cervix:
2	chr21:44596408..44597544-chr21:44922093..44923863,11	MCF-7	breast:
3	chr21:44596809..44598374-chr21:45064063..45066950,2	K562	blood:
4	chr21:44596483..44597010-chr21:44689136..44690000,2	K562	blood:
5	chr21:44594665..44597116-chr21:44751236..44753866,2	MCF-7	breast:
6	chr21:44596413..44596968-chr21:44866121..44867152,3	K562	blood:
7	chr21:44596910..44599943-chr21:44921245..44924609,4	MCF-7	breast:
8	chr21:44598660..44599239-chr21:44846133..44847235,3	MCF-7	breast:
9	chr21:44599423..44602035-chr21:44607332..44609772,2	MCF-7	breast:
10	chr21:44598282..44598954-chr21:44689291..44689941,2	MCF-7	breast:
11	chr21:44596497..44597381-chr21:44847015..44847854,5	K562	blood:
12	chr21:44596524..44597433-chr21:45039423..45039934,2	K562	blood:
13	chr21:44588420..44591147-chr21:44596861..44598398,2	MCF-7	breast:
14	chr21:44596583..44597347-chr21:44905726..44906251,2	MCF-7	breast:
15	chr21:44595827..44599164-chr21:44845631..44847666,4	MCF-7	breast:
16	chr21:44593589..44596028-chr6:20403281..20405079,2	K562	blood:
17	chr21:44595581..44597977-chr21:44722947..44725523,2	K562	blood:
18	chr21:44595506..44597559-chr21:44837131..44839693,2	MCF-7	breast:
19	chr21:44596549..44597371-chr21:45065165..45066013,2	K562	blood:
20	chr21:44596666..44597314-chr21:44816535..44817335,2	MCF-7	breast:
21	chr21:44595907..44598227-chr21:44599190..44600855,2	MCF-7	breast:
22	chr21:44594966..44597591-chr21:44845721..44847643,2	K562	blood:
23	chr21:44596001..44597609-chr21:45065167..45067189,15	MCF-7	breast:
24	chr21:44590676..44595436-chr21:44598084..44601687,4	K562	blood:
25	chr21:44597167..44598866-chr21:44766112..44768773,2	MCF-7	breast:
26	chr21:44595907..44598227-chr21:44599190..44600855,2	MCF-7	breast:
27	chr21:44596708..44597705-chr21:44847238..44847861,3	MCF-7	breast:
28	chr21:44582210..44584160-chr21:44594583..44597207,2	MCF-7	breast:
29	chr21:44558793..44559748-chr21:44595983..44597245,4	MCF-7	breast:
30	chr21:44595975..44600241-chr21:44843202..44849395,11	MCF-7	breast:
31	chr21:44596870..44597527-chr21:44832462..44833303,2	Hela-S3	cervix:
32	chr21:44558924..44559647-chr21:44596413..44597304,3	MCF-7	breast:
33	chr21:44596302..44600320-chr21:44763162..44765941,4	MCF-7	breast:
34	chr21:44596396..44597313-chr21:45065147..45065707,2	MCF-7	breast:
35	chr21:44595496..44597017-chr21:44829022..44831353,2	MCF-7	breast:
36	chr21:44596467..44597366-chr21:45066269..45067210,6	K562	blood:
37	chr21:44595703..44598660-chr21:45028207..45031192,2	MCF-7	breast:
38	chr21:44596353..44597867-chr21:44760877..44763023,2	MCF-7	breast:
39	chr21:44597096..44598685-chr21:44750362..44752904,2	MCF-7	breast:
40	chr21:44595418..44598407-chr21:45007465..45009708,2	MCF-7	breast:
41	chr21:44596450..44597355-chr21:44683459..44684057,2	MCF-7	breast:
42	chr21:44596361..44597517-chr21:45066264..45067091,4	MCF-7	breast:
43	chr21:44597633..44599530-chr21:44922531..44924601,2	MCF-7	breast:
44	chr21:44595798..44598770-chr21:45063265..45067849,4	MCF-7	breast:
45	chr21:44595103..44597994-chr21:45059971..45061669,2	MCF-7	breast:
46	chr21:44588285..44592993-chr21:44594253..44598657,5	MCF-7	breast:
47	chr21:44597050..44598895-chr21:44866871..44869287,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000112242	chromatin interactions
ENSG00000228120	chromatin interactions
ENSG00000188660	chromatin interactions
ENSG00000134297	chromatin interactions
ENSG00000237864	chromatin interactions
ENSG00000160202	chromatin interactions
ENSG00000177119	chromatin interactions
ENSG00000142178	chromatin interactions

Extended variants
information (count: 209 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:209 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs370774218	chr21:44595892-44595893	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
2	rs116079470	chr21:44595909-44595910	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs551995449	chr21:44595916-44595917	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs112946234	chr21:44595932-44595933	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs537465375	chr21:44595949-44595950	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs149337348	chr21:44595978-44595979	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs560182519	chr21:44595982-44595983	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs568348002	chr21:44596011-44596012	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs1473776	chr21:44596019-44596020	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs144675884	chr21:44596063-44596064	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs111480458	chr21:44596064-44596065	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs572189198	chr21:44596094-44596095	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs539884327	chr21:44596136-44596137	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs535220423	chr21:44596141-44596142	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs148518091	chr21:44596153-44596154	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs576349162	chr21:44596172-44596173	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs73906479	chr21:44596181-44596182	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs561773812	chr21:44596184-44596185	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs553156141	chr21:44596190-44596191	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs190984523	chr21:44596200-44596201	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs184000454	chr21:44596217-44596218	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs533365668	chr21:44596220-44596221	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs367847581	chr21:44596225-44596226	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs564042402	chr21:44596242-44596243	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs531469634	chr21:44596245-44596246	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs914195	chr21:44596272-44596273	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs568111114	chr21:44596283-44596284	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs73376220	chr21:44596365-44596366	Weak transcription Enhancers Genic enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs547725493	chr21:44596427-44596428	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs76513461	chr21:44596443-44596444	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs539279362	chr21:44596447-44596448	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs187799938	chr21:44596454-44596455	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs150648038	chr21:44596469-44596470	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs537194137	chr21:44596478-44596479	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs538764437	chr21:44596514-44596515	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs140890135	chr21:44596527-44596528	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs374160203	chr21:44596543-44596544	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs368668945	chr21:44596570-44596571	Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs550679303	chr21:44596615-44596616	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs373666010	chr21:44596619-44596620	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs372144101	chr21:44596630-44596631	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs377023905	chr21:44596649-44596650	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs541279865	chr21:44596685-44596686	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs192482156	chr21:44596701-44596702	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs578098171	chr21:44596717-44596718	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs115694724	chr21:44596747-44596748	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs78930798	chr21:44596760-44596761	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
48	rs563936860	chr21:44596778-44596779	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs375240669	chr21:44596786-44596787	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs62217722	chr21:44596789-44596790	Enhancers Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Down syndrome	17412756	CNVD
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Renal cell carcinoma	19461508	CNVD
Seminomas	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
lymphocytic leukemia	21291569	CNVD
Melanoma	18172304	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Wilms tumour	21544195	CNVD
Ewing''s sarcoma	17952124	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute myeloid leukemia	16864856	CNVD
Mental retardation	21031080	CNVD
Polymicrogyria	21031080	CNVD
periventricular nodular heterotopia	21031080	CNVD
Myelodysplastic syndrome	21606161	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Breast cancer	21858162	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17899364	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Breast cancer	21364760	CNVD
Glioblastoma multiforme	18628472	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Ewing''s sarcoma	21437220	CNVD
Lung adenocarcinoma	17086460	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Ovarian neoplasms	16753589	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute myeloid leukemia	21358987	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	23341502	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Prostate cancer	18632612	CNVD
Neuroblastoma	20406844	CNVD
Acute myeloid leukemia	21251322	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	17142309	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:434 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:44586200-44597000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
2	chr21:44590200-44596600	Weak transcription	Brain Inferior Temporal Lobe	brain
3	chr21:44592400-44596800	Weak transcription	Cortex derived primary cultured neurospheres	brain
4	chr21:44593600-44596200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
5	chr21:44593600-44596400	Weak transcription	Placenta Amnion	Placenta Amnion
6	chr21:44593600-44596600	Enhancers	Brain Germinal Matrix	brain
7	chr21:44593600-44597000	Weak transcription	Psoas Muscle	Psoas
8	chr21:44593800-44596200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
9	chr21:44593800-44596400	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
10	chr21:44593800-44596400	Weak transcription	Primary T helper cells PMA-I stimulated	--
11	chr21:44593800-44596400	Weak transcription	Thymus	Thymus
12	chr21:44593800-44596600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr21:44593800-44596600	Weak transcription	Primary monocytes fromperipheralblood	blood
14	chr21:44593800-44596600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
15	chr21:44593800-44596600	Weak transcription	Primary T helper cells fromperipheralblood	blood
16	chr21:44593800-44596600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
17	chr21:44593800-44596600	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
18	chr21:44593800-44596600	Weak transcription	Liver	Liver
19	chr21:44593800-44596600	Weak transcription	Left Ventricle	heart
20	chr21:44593800-44596600	Weak transcription	Rectal Mucosa Donor 31	rectum
21	chr21:44593800-44596600	Weak transcription	Right Atrium	heart
22	chr21:44593800-44596800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
23	chr21:44593800-44596800	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
24	chr21:44593800-44596800	Enhancers	Fetal Thymus	thymus
25	chr21:44593800-44597000	Weak transcription	HUES48 Cell Line	embryonic stem cell
26	chr21:44593800-44597000	Weak transcription	HUES64 Cell Line	embryonic stem cell
27	chr21:44593800-44597000	Weak transcription	Primary hematopoietic stem cells	blood
28	chr21:44593800-44597000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
29	chr21:44593800-44599000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
30	chr21:44593800-44599800	Enhancers	Placenta	Placenta
31	chr21:44593800-44601600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
32	chr21:44594000-44596400	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
33	chr21:44594000-44596400	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
34	chr21:44594000-44596400	Weak transcription	Primary T killer memory cells from peripheral blood	blood
35	chr21:44594000-44596400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
36	chr21:44594000-44596400	Weak transcription	GM12878-XiMat	blood
37	chr21:44594000-44596600	Weak transcription	Primary neutrophils fromperipheralblood	blood
38	chr21:44594000-44596600	Weak transcription	Primary B cells from cord blood	blood
39	chr21:44594000-44596600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
40	chr21:44594000-44596600	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
41	chr21:44594000-44596600	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
42	chr21:44594000-44596600	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
43	chr21:44594000-44596600	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
44	chr21:44594000-44596600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
45	chr21:44594000-44596600	Weak transcription	Brain Substantia Nigra	brain
46	chr21:44594000-44596600	Weak transcription	Esophagus	oesophagus
47	chr21:44594000-44596600	Weak transcription	Fetal Lung	lung
48	chr21:44594000-44596600	Enhancers	HepG2	liver
49	chr21:44594000-44596600	Weak transcription	HSMM	muscle
50	chr21:44594000-44596600	Weak transcription	NH-A	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links